In the race to forge the next Keytruda from PD-(L)1xVEGF bispecific antibodies, Pfizer and the BioNTech-Bristol Myers Squibb alliance are split on how to position overall survival—the gold-standard ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Pfizer (PFE) and BioNTech SE (BNTX). According to TipRanks.com, Schott is a 4-star analyst with an average return of 4 ...

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of ...

The CHMP’s recommendation will be reviewed by the European Commission (EC), which is expected to make its final decision soon. Pfizer and BioNTech have already initiated manufacturing of the ...

Last year, the High Court ruled that one of Moderna’s patents relating to the messenger RNA (mRNA) technology, which underpinned its COVID-19 vaccine, was valid and that Pfizer and BioNTech’s ...

A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make their COVID-19 vaccine. Siding with Moderna, an American pharmaceutical firm ...

Due to Pfizer’s underperformance relative to its peers over the past year, Wall Street analysts remain cautious about the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Jefferies analyst Akash Tewari maintained a Buy rating on Pfizer today and set a price target of $35.00. Claim 55% Off TipRanks. Unlock trusted, data-backed investing tools with T ...

There are no hantaviruses in the ingredient list of the Pfizer COVID vaccine, now called Comirnaty. According to Pfizer’s ...